Polysomnography Devices Companies
Polysomnography (PSG) is a diagnostic test used in sleep medicine to study sleep patterns and diagnose sleep disorders. Various companies specialize in the manufacturing and development of polysomnography devices.
Polysomnography (PSG) is a diagnostic test used in sleep medicine to study sleep patterns and diagnose sleep disorders. Various companies specialize in the manufacturing and development of polysomnography devices.
Latest Polysomnography Devices Companies Updates:
Philips (Netherlands): Launched its Somnolyzer 24G device in October 2023, featuring advanced sleep staging algorithms and improved sensor technology for comprehensive sleep analysis at home or in ambulatory settings.
Emfit (US): Secured FDA clearance for its Quell® wearable for treating chronic insomnia in December 2023, expanding its portfolio of non-invasive sleep therapy solutions.
Cadwell Laboratories, Inc. (US): Announced a strategic partnership with Neurobit (Israel) in September 2023 to develop and integrate AI-powered sleep staging algorithms into existing PSG devices, enhancing diagnostic capabilities.
Nox Medical (US): Received FDA approval for its Nox A1+ Home Sleep Testing System in July 2023, offering a compact and user-friendly option for home-based sleep apnea diagnosis.
Brainlab (Germany): Showcased its new Quantinuum sleep EEG System at a recent medical conference, highlighting its potential for advanced sleep monitoring and research applications.
List of Polysomnography Devices Key companies in the market:
Polysomnography Devices Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)